Gupta, S., Ballman, K. V., Apolo, A. B., Sridhar, S. S., Chen, R. C., Chan, T. A., Wen, Y., Berg, S. A., Yen, A. E., Baghaie, S., Singh, P., Reimers, M. A., Morris, M. J., Galsky, M. D., Rosenberg, J. E. (2026). MAIN-CAV: Phase III randomized trial of maintenance cabozantinib and avelumab versus avelumab after first-line platinum-based chemotherapy (PBC) in patients (pts) with locally advanced/metastatic urothelial cancer (la/mUC; Alliance A032001).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.4514